Z Factor Overview

  • Founded
  • 2014

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Z Factor General Information

Description

Developer of a drug discovery company intended to identify therapeutic agents to treat alpha-1-antitrypsin deficiency. The company's activities are focused on designing and developing novel therapeutic agents to correct the misfolding of the Z variant of alpha-1-antitrypsin, thereby addressing an important and unmet medical need where current treatments are limited to lung or liver transplantation and augmentation therapy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • The Dorothy Hodgkin Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Z Factor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 16-Feb-2021 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 03-May-2017 00.000 000.00 000.00 Completed Startup
1. Early Stage VC (Series A) 05-Feb-2015 $1.66M $1.66M 00.000 Completed Startup
To view Z Factor’s complete valuation and funding history, request access »

Z Factor Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.00 00.00 00 00.00 00.000
To view Z Factor’s complete cap table history, request access »

Z Factor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a drug discovery company intended to identify therapeutic agents to treat alpha-1-antitrypsin deficiency. T
Drug Discovery
Cambridge, United Kingdom
000.00
000000&0 000.00

00000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
0000 000000000
Cambridge, United Kingdom
000 As of 0000
00000
0.000 0000-00-00
000000&0 00000

0000

. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo c
0000000000000
San Diego, CA
00 As of 0000
00.000
0.00 0000-00-00
0000000000 0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Z Factor Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kymab Formerly VC-backed Cambridge, United Kingdom 000 00000 000000&0 00000
0000 Venture Capital-Backed San Diego, CA 00 00.000 0000000000 0
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 0000000000 0 00000
0000000 Venture Capital-Backed Framingham, MA 00 000.00 00000000000 000.00
000000000 Formerly VC-backed San Diego, CA 00 00000 000000&0 00000
You’re viewing 5 of 36 competitors. Get the full list »

Z Factor Patents

Z Factor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202108497-D0 Compounds Pending 15-Jun-2021
GB-202108498-D0 Compunds Pending 15-Jun-2021
GB-202108501-D0 Compounds Pending 15-Jun-2021
GB-202108499-D0 Compounds Pending 15-Jun-2021
GB-202108542-D0 Compounds and their use for the treatment of alpha1-antitrypsin deficiency Pending 15-Jun-2021
To view Z Factor’s complete patent history, request access »

Z Factor Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cambridge Enterprise Venture Capital Minority 000 0000 000000 0
Cambridge Innovation Capital Venture Capital Minority 000 0000 000000 0
Medicxi Venture Capital Minority 000 0000 000000 0
To view Z Factor’s complete investors history, request access »